Authors:
WILLIS CL
DAUENHAUER DL
HUMPHREY JM
CHAMBERLIN AR
BULLER AL
MONAGHAN DT
BRIDGES RJ
Citation: Cl. Willis et al., METHYLATION OF THE NMDA RECEPTOR AGONIST L-TRANS-2,3-PYRROLIDINE-DICARBOXYLATE - ENHANCED EXCITOTOXIC POTENCY AND SELECTIVITY, Toxicology and applied pharmacology, 144(1), 1997, pp. 45-55
Citation: Al. Buller et Dt. Monaghan, PHARMACOLOGICAL HETEROGENEITY OF NMDA RECEPTORS - CHARACTERIZATION OFNR1A NR2D HETEROMERS EXPRESSED IN XENOPUS OOCYTES/, European journal of pharmacology, 320(1), 1997, pp. 87-94
Authors:
BULLER AL
LARSON HC
SCHNEIDER BE
BEATON JA
MORRISETT RA
MONAGHAN DT
Citation: Al. Buller et al., THE MOLECULAR-BASIS OF NMDA RECEPTOR SUBTYPES - NATIVE RECEPTOR DIVERSITY IS PREDICTED BY SUBUNIT COMPOSITION, The Journal of neuroscience, 14(9), 1994, pp. 5471-5484
Authors:
BULLER AL
HASTINGS GA
KIRKNESS EF
FRASER CM
Citation: Al. Buller et al., SITE-DIRECTED MUTAGENESIS OF N-LINKED GLYCOSYLATION SITES ON THE GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTOR ALPHA-1 SUBUNIT, Molecular pharmacology, 46(5), 1994, pp. 858-865